These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 33282191

  • 1. The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI): A series of four guidance documents for academics, drug regulators and industry partners.
    Corris PA, Nikkho S, Fernandes P.
    Pulm Circ; 2020; 10(4):2045894020963031. PubMed ID: 33282191
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pulmonary vascular resistance index during coronary artery bypass surgery with aprotinin.
    Toikkanen V, Rinne T, Laurikka J, Porkkala H, Tarkka M, Mennander A.
    Scand J Clin Lab Invest; 2017 Sep; 77(5):315-320. PubMed ID: 28460544
    [Abstract] [Full Text] [Related]

  • 6. What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation.
    Chiu P, Russo MJ, Davies RR, Addonizio LJ, Richmond ME, Chen JM.
    J Heart Lung Transplant; 2012 Jan; 31(1):61-6. PubMed ID: 22019236
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Filling the pipeline for neglected diseases: creation of a medicinal chemistry-centric international drug discovery institute [iDDi].
    Kozikowski AP, Reitz AB.
    Drug Discov Today; 2008 Feb; 13(3-4):97-8. PubMed ID: 18275906
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endothelin-A receptor blockade in porcine pulmonary hypertension.
    Ambalavanan N, Philips JB, Bulger A, Oparil S, Chen YF.
    Pediatr Res; 2002 Dec; 52(6):913-21. PubMed ID: 12438670
    [Abstract] [Full Text] [Related]

  • 14. The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure.
    Cooper CJ, Jevnikar FW, Walsh T, Dickinson J, Mouhaffel A, Selwyn AP.
    Am J Cardiol; 1998 Sep 01; 82(5):609-14. PubMed ID: 9732889
    [Abstract] [Full Text] [Related]

  • 15. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
    Hughes CE.
    Drug Alcohol Rev; 2007 Jul 01; 26(4):363-8. PubMed ID: 17564871
    [Abstract] [Full Text] [Related]

  • 16. EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).
    Kiely DG, Levin D, Hassoun P, Ivy DD, Jone PN, Bwika J, Kawut SM, Lordan J, Lungu A, Mazurek J, Moledina S, Olschewski H, Peacock A, Puri GD, Rahaghi F, Schafer M, Schiebler M, Screaton N, Tawhai M, Van Beek EJ, Vonk-Noordegraaf A, Vanderpool RR, Wort J, Zhao L, Wild J, Vogel-Claussen J, Swift AJ.
    Pulm Circ; 2019 Mar 18; 9(3):2045894019841990. PubMed ID: 30880632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Elevated pulmonary vascular resistance and cardiac transplantation.
    Addonizio LJ, Gersony WM, Robbins RC, Drusin RE, Smith CR, Reison DS, Reemtsma K, Rose EA.
    Circulation; 1987 Nov 18; 76(5 Pt 2):V52-5. PubMed ID: 3311456
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary hemodynamic response to dopamine and dobutamine in hyperoxic and in hypoxic dogs.
    Lejeune P, Leeman M, Deloof T, Naeije R.
    Anesthesiology; 1987 Jan 18; 66(1):49-54. PubMed ID: 3800034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.